Company Share Buybacks for Owner-Managers: Income vs Capital Treatment in 2026/27
A share buyback can be taxed as a dividend or as a capital gain, and the difference in your tax bill can be enormous. Here is how HMRC's 'substantial reduction' test works and what an owner-manager needs to satisfy.
Why Owner-Managers Use Share Buybacks
A share buyback (technically a "purchase of own shares") is when a company buys back shares from one of its shareholders, reducing that shareholder's stake — often used by owner-managed companies to:
- Buy out a retiring or departing co-founder/shareholder.
- Resolve a shareholder dispute by exiting one party cleanly.
- Facilitate succession planning, allowing an older generation to extract value while transferring control.
- Return surplus cash to a shareholder without a full company sale.
The tax treatment of the payment received by the selling shareholder is the central question — and it can differ dramatically depending on whether specific statutory conditions are met.
Default Position: Distribution (Dividend) Treatment
Unless the buyback qualifies for capital treatment under the specific statutory rules, the amount paid to the seller above the original amount subscribed for the shares is treated as a distribution — taxed exactly like a dividend, at the seller's marginal dividend tax rate:
| Band | Dividend tax rate (2026/27) |
|---|---|
| Basic rate | 10.75% |
| Higher rate | 35.75% |
| Additional rate | 39.35% |
For a higher or additional-rate taxpayer receiving a substantial buyback payment, this default treatment can result in a very large tax bill.
Capital Treatment: The Alternative
If specific statutory conditions are met (set out in the Corporation Tax Act 2010, Part 23, Chapter 3), the payment can instead be treated as consideration for the disposal of a capital asset — taxed under capital gains tax rules:
| Scenario | CGT rate (2026/27) |
|---|---|
| Standard capital gains treatment | 18% (basic rate) / 24% (higher rate) |
| Business Asset Disposal Relief applies (if separately eligible) | 18% flat rate, up to £1 million lifetime limit |
The difference between paying up to 39.35% (dividend treatment) versus 18-24% (capital treatment) on a significant buyback sum is often the single biggest tax planning question in these transactions.
The Key Conditions for Capital Treatment
| Condition | What it requires |
|---|---|
| Substantial reduction test | The seller's shareholding (and connected persons') must fall to 75% or less of the pre-buyback percentage |
| Connection test | The seller's overall connection to the company (broadly interest above 30% including associates) must also generally fall below the relevant threshold after the buyback |
| Trade benefit test | The buyback must be shown to benefit the company's trade, not be primarily for tax avoidance |
| Residence requirement | The seller must generally be UK resident in the tax year of the buyback |
| Ownership period | Shares generally must have been owned for at least 5 years (can be reduced to 3 years for shares acquired from a spouse/civil partner or on death) |
All conditions must be satisfied together — meeting the substantial reduction test alone is not sufficient if, for example, the trade benefit test is not also met.
Worked Example: Why the Test Matters
| Scenario | Outcome |
|---|---|
| Shareholder owns 40% before buyback; sells shares reducing them to 10% after | 10% is 25% of the original 40% — meets the substantial reduction test (75% or less threshold) |
| Shareholder owns 40% before buyback; sells shares reducing them to 35% after | 35% is 87.5% of the original 40% — fails the substantial reduction test (above 75% threshold), so dividend treatment likely applies |
A buyback that only modestly reduces a shareholder's stake is much less likely to qualify for capital treatment than one that substantially exits or significantly reduces their involvement.
Seeking HMRC Clearance
Because the conditions are fact-specific and the tax consequences of getting it wrong are significant, companies planning a buyback intended to qualify for capital treatment should apply for advance clearance from HMRC under the statutory clearance procedure before completing the transaction. This gives certainty that HMRC agrees the conditions are met, protecting both the company and the selling shareholder from an unexpected reclassification (and associated tax liability, interest and potential penalties) after the transaction has already completed.
Practical Steps for Owner-Managers Considering a Buyback
- Model both the dividend and capital treatment tax outcomes for the specific transaction before proceeding.
- Assess the seller's shareholding before and after against the substantial reduction test.
- Document clearly how the buyback benefits the company's trade (useful both for the clearance application and as a defensible record).
- Apply for HMRC clearance before completing the transaction.
- Check separately whether Business Asset Disposal Relief conditions are met if capital treatment is confirmed, as this could further reduce the effective tax rate.
- Get company law advice alongside tax advice — purchase of own shares also involves company law requirements (distributable reserves, statutory declarations of solvency in some cases) separate from the tax analysis.
Frequently asked questions
Related reading
Annual Investment Allowance 2026: £1m Limit and Timing Your Capital Spend
AIA gives 100% first-year relief on up to £1m of plant and machinery. How to time purchases around your accounting year, pool interactions, and group company rules.
UK R&D Merged Scheme 2026: RDEC 20% Rate and ERIS for SMEs
The R&D merged scheme replaced SME R&D and RDEC from April 2024. RDEC rate is 20% (net 15%), ERIS gives loss-making R&D-intensive SMEs 27% net benefit. What qualifies and how to claim.
UK R&D Tax Relief for SMEs: PAYE Cap and Submission Rules 2026
How UK SME R&D tax relief works in 2026 -- the PAYE cap calculation, merged scheme, qualifying costs, and the Additional Information Form required for all claims.